Lipovectra

Lipovectra develops medicines that turn fat from a disease driver into a therapeutic target. Dysfunctional white adipose tissue (WAT) is linked to 70% of human diseases [1,2], yet lacks approved targeted therapies. Our lead candidate, MLT-001, converts white fat into thermogenic beige fat, an appr... Read more